NIH-funded research NIH-funded research

Investigating blood-based markers for Alzheimer's disease risk in veterans

Official title: The epigenetics of dementia risk in the Million Veteran Program

Funded at VA Boston Health Care System · NIH-10918836 · Data updated 2026-11-12

This study is looking at how changes in your blood's DNA can help us figure out if older veterans might be at risk for Alzheimer's and related memory issues, with the hope of creating easy blood tests to catch these problems early and keep track of them better.

More Dementia research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Boston Health Care System
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2024
Project endJune 30, 2028
Funding year2024
NIH project number1I01BX006549-01
Project IDNIH-10918836 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are veterans aged 65 and older, particularly those with a family history of Alzheimer's disease or related dementias.

Less likely to help

Patients under the age of 65 or those without a risk of Alzheimer's disease or related dementias may not benefit from this research.

What this research studies

This research focuses on understanding how changes in DNA methylation in the blood can indicate the risk of Alzheimer's disease and related dementias (ADRD) among veterans aged 65 and older. By analyzing data from the Million Veteran Program, the study aims to identify specific DNA markers that could lead to the development of simple blood tests for diagnosing and monitoring ADRD. The approach is less invasive and more cost-effective compared to current diagnostic methods, which often involve expensive imaging techniques. Ultimately, the goal is to improve early detection and treatment tracking for those at risk or diagnosed with ADRD.

Why it matters

Potential benefit: If successful, this research could lead to the development of affordable and non-invasive blood tests for early detection of Alzheimer's disease and related dementias.

How similar studies have gone: Previous research has shown promise in using blood-based biomarkers for Alzheimer's diagnosis, indicating that this approach could be a significant advancement in the field.

Where this research is happening

  • VA Boston Health Care System
    Boston, United States
    Active

Researchers

  • Principal investigator: Miller, Mark W — VA Boston Health Care System
  • Study coordinator: Miller, Mark W

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.